ghk cu injectable clinical trial human The Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health GHK-Cu Peptides Before and After:
Description
Side Effects and Safety Considerations Common: Mild injection site redness (resolves within an hour), transient fatigue during the first one to two days of use, and occasional light headache
An intranasal spray solution of B12, also called Nascobal, with the same indications, was FDA approved in January 2005
Vegan, Gluten-Free, Soy-Free, Dairy-Free
Some users report subjective changes within 2-3 weeks
B-12 injections deliver a highly absorbable dose of vitamin B-12an essential nutrient for red blood cell production, energy metabolism, and nervous system function
